Translating Science into Survival: Report on the  Inaugural International Cancer Immunotherapy  Conference.
The inaugural International Cancer Immunotherapy Conference, cohosted by the Cancer Research Institute (CRI), the American Association for Cancer Research (AACR), the Association for Cancer Immunotherapy (CIMT), and the European Academy of Tumor Immunology (EATI), was held in New York City on September 16–19, 2015. The conference brought together nearly 1,400 scientists, clinicians, regulators, patient advocates, and other stakeholders to discuss the latest scientific developments in cancer immunology and immunotherapy, as well as the regulatory hurdles facing new drug development. This conference report summarizes the main themes that emerged during the 4-day meeting.
Vanessa M
VM
Hubbard-Lucey
Matthew J
MJ
Tontonoz
D000818:Animals; D019496:Cancer Vaccines / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D016896:Treatment Outcome
D019496:Cancer Vaccines